Prateek Dhawan has joined Accel Partners as an India-based principal on the firm's growth equity team. he previously was a VP with Goldman Sachs Investment Partners, where he led Indian investment activities.
2 min read · 02 June 2010
Constellation Pharmaceuticals Inc., a Cambridge, Mass.-based developer of drugs that target selective regulators of epigenetic function, has raised $4.8 million in additional Series B funding led by S.R. One Ltd. The round is now closed at $22 million, including a $17.2 million first close announced last summer. Other backers include Altitude Life Science Ventures, Third Rock Ventures, The Column Group and Venrock. The company has raised a total of $54 million.
3 min read · 02 June 2010
Ablexis LLC, a San Francisco-based developer of a platform for antibody drug discovery, has raised $12 million in Series A funding. Third Rock Ventures led the round, and was joined by Pfizer Venture Investments.
4 min read · 02 June 2010
GSI Commerce Inc. (Nasdaq: GSIC) has acquired FetchBack Inc., a Tempe, Ariz.-based provider of re-targeting solutions for online advertisers. No financial terms were disclosed. FetchBack had raised VC funding from Metamorphic Ventures.
4 min read · 02 June 2010
Kudzu Interactive, an Atlanta-based operator of an online and mobile ordering and ecommerce solution for the casual dining takeout food market (Snapfinger.com), has raised $7 million in Series B funding led by Norwest Venture Partners. The company previously raised $3 million.
3 min read · 02 June 2010
1 min read · 01 June 2010
Mocana, a San Francisco-based provider of security software for devices, has raised an undisclosed amount of third-round funding. Symantec Corp. led the round, and was joined by return backers Southern Cross Venture Partners and Shasta Ventures.
4 min read · 01 June 2010
SynapDx Corp., a Waltham, Mass.-based provider of diagnostic testing for the early detection of autism, has raised $9 million in Series A funding. Backers include Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners.
1 min read · 01 June 2010
1 min read · 01 June 2010
Tetraphase Pharmaceuticals Inc., a Watertown, Mass.-based developer of synthetic chemistry technology for drug discovery and development, has raised $45 million in Series C funding. Excel Venture Management led the round, and was joined by return backers CMEA Ventures, Fidelity Biosciences, Flagship Ventures, Mediphase Venture Partners and Skyline Ventures.
3 min read · 01 June 2010
